1,173 results on '"Pavletic, Steven Z."'
Search Results
152. Histopathologic Diagnosis of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report
153. Unique Abnormalities of CD4 + and CD8 + Central Memory Cells Associated with Chronic Graft-versus-Host Disease Improve after Extracorporeal Photopheresis
154. Biology and Management of Chronic Graft-Versus-Host Disease
155. Contributors
156. Hematopoietic Stem Cell Transplantation
157. Localization of Sclerotic-type Chronic Graft-vs-Host Disease to Sites of Skin Injury: Potential Insight Into the Mechanism of Isomorphic and Isotopic Responses
158. Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation
159. Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease—results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health
160. Calcinosis Cutis in the Setting of Chronic Skin Graft-Versus-Host Disease
161. Metabolic reprogramming augments potency of human pSTAT3–inhibited iTregs to suppress alloreactivity
162. Quality of Life in Patients With Skin of Color and Chronic Graft-vs-Host Disease
163. Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant
164. NCCN Guidelines: Pretransplant Recipient Evaluation and Management of Graft-Versus-Host Disease
165. Glycolytic metabolism of pathogenic T cells enables early detection of GvHD by13C-MRI
166. Human pSTAT3-Inhibited Itregs Prevent Gvhd, Maintain Anti-Leukemia Immunity, and Increase Their Potency after Metabolic Reprogramming
167. Clinical characteristics and cytokine biomarkers in patients with chronic graft‐vs‐host disease persisting seven or more years after diagnosis
168. Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease
169. Motor ability, function, and health-related quality of life as correlates of symptom burden in patients with sclerotic chronic graft-versus-host disease receiving imatinib mesylate
170. Factors Associated with Subsequent Cancers in Patients with Moderate or Severe Chronic Graft-Versus-Host Disease after Transplant for Hematologic Malignancy
171. Single-Cell RNA-Seq Identifies Potentially Pathogenic B Cell Populations That Uniquely Circulate in Patients with Chronic Gvhd
172. Clinical Characterization and Cytokine Profile of Fatigue in Patients with Chronic Gvhd
173. Trial in Progress: A Phase 3 Study of Itacitinib or Placebo in Combination with Corticosteroids As Initial Treatment for Chronic Graft-Versus-Host Disease (GRAVITAS-309)
174. Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma
175. Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation
176. Magnetic Resonance Imaging in Sclerotic-Type Chronic Graft-vs-Host Disease
177. Feasibility of Allogeneic Hematopoietic Stem Cell Transplantation for Autoimmune Disease: Position Statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute–Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005
178. Rippled skin, fasciitis, and joint contractures
179. The Isomorphic Response in Morphealike Chronic Graft-vs-Host Disease
180. Technology Insight: hematopoietic stem cell transplantation for systemic rheumatic disease
181. Clinical utilization of Chimeric Antigen Receptors T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL) – an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)
182. Chronic graft versus host disease of oral mucosa: Review of available therapies
183. Unrelated Donor Marrow Transplantation for B-Cell Chronic Lymphocytic Leukemia After Using Myeloablative Conditioning: Results From the Center for International Blood and Marrow Transplant Research
184. Considerations when designing a clinical trial of haematopoietic stem cell transplantation for autoimmune disease
185. Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantation
186. Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Autoimmune Disease
187. CD34-selected versus unmanipulated grafts for severe rheumatoid arthritis: Comment on the article by Moore et al
188. High-dose cyclophosphamide in multiple sclerosis patients undergoing autologous stem cell transplantation
189. 425 - Early Experience with a Radiation- and Serotherapy-Free Reduced Intensity Conditioning Platform for Allogeneic Bone Marrow Transplantation (alloBMT) in Primary Immunodeficiency (PID)
190. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis
191. Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study
192. 508 - Pleuroparenchymal Fibroelastosis in Patients with Chronic Graft-Versus-Host-Disease: A Rare Delayed Complication of Hematopoietic Stem Cell Transplantation
193. 409 - Correlation of Patient-Reported Outcomes with Clinical Organ Responses: Data from the Belumosudil Chronic Graft-Versus-Host Disease Studies
194. 387 - Belumosudil for Patients with Chronic Graft-Versus-Host Disease: Combined Analysis of Failure-Free Survival (FFS) in the KD025-208 and Pivotal Rockstar Trials
195. Oral Complications of Chronic Graft-Versus-Host Disease
196. Accompanying editorial on paper Neutrophil extracellular traps (NETs) contribute to Pathological Changes of ocular graft-vs.-Host Disease (oGVHD) dry eye: Implications for novel Biomarkers and Therapeutic Strategies by Seungwon An et al.
197. Incidence of Epstein-Barr Virus (EBV) Detection in the Blood, Pre-Emptive Therapy, and EBV-Posttransplantation Lymphoproliferative Disorder (EBV-PTLD) after Allogeneic Hematopoietic Cell Transplantation (HCT) across a Broad Range of HCT Approaches and All Graft Sources
198. Chronic Graft-Versus-Host Disease Abrogates Standard Risk Factors for Malignancy Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
199. Salivary Zymogen Granule Protein 16B Drops at Onset of Chronic Graft-Versus-Host Disease: A Possible Salivary Biomarker for Oral Chronic Graft-Versus-Host Disease
200. Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Transplantation and Cellular Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.